Capsina (Capsaicin)

What Is Capsina and What Is It Used For?

Capsina is a topical analgesic cream whose active ingredient is capsaicin, a naturally occurring vanilloid compound found in chili peppers of the Capsicum genus. The cream contains 0.075% capsaicin (0.75 mg per gram of cream) and is applied directly to the skin over areas affected by neuropathic pain. It is classified as a topical analgesic and counterirritant, and its primary licensed indication is the treatment of pain associated with post-herpetic neuralgia (PHN) in adults.

Post-herpetic neuralgia is a common and often debilitating complication of herpes zoster (shingles), a condition caused by reactivation of the varicella-zoster virus. PHN is characterized by persistent, burning, shooting, or stabbing pain in the area where the shingles rash occurred, and it can last for months or even years after the rash has healed. The condition predominantly affects older adults, with the risk increasing significantly after the age of 50. Studies estimate that approximately 10–18% of shingles patients develop PHN, rising to 30% or more in those over 80 years of age.

Capsaicin acts through a unique mechanism that targets the transient receptor potential vanilloid 1 (TRPV1) receptor, which is expressed on nociceptive (pain-sensing) nerve fibers in the skin. When capsaicin is applied topically, it initially activates these receptors, causing a characteristic burning or warming sensation. With repeated application, the continuous activation leads to desensitization of the TRPV1-expressing nerve endings and reversible degeneration of epidermal nerve fibers. This process depletes stores of substance P, a neuropeptide involved in transmitting pain signals from peripheral nerves to the central nervous system, ultimately reducing the sensation of pain.

Capsaicin has been used in traditional medicine for centuries, and its analgesic properties have been the subject of extensive scientific investigation. Modern formulations like Capsina provide a standardized, controlled dose of capsaicin that can be reliably applied to affected areas. While capsaicin-based products are available in various concentrations worldwide, including both prescription and over-the-counter formulations, Capsina at 0.075% represents a low-concentration topical option specifically designed for regular daily application over sustained periods. Higher-concentration capsaicin patches (8%) are also available for clinic-administered treatment of neuropathic pain conditions.

It is important to note that capsaicin, the active ingredient in Capsina, may also be approved for other pain conditions not specifically mentioned in this product information. Always consult your doctor, pharmacist, or other healthcare professional if you have questions about its use, and follow their instructions carefully.

What Should You Know Before Using Capsina?

Before starting treatment with Capsina, it is essential to understand the contraindications, warnings, and precautions associated with this medication. While capsaicin is generally well tolerated when used as directed, there are important safety considerations that patients and healthcare providers should be aware of to ensure safe and effective treatment.

Contraindications

Allergic reactions to capsaicin are uncommon but can occur. If you have a known allergy to chili peppers or to any excipients in the cream formulation, you should avoid using Capsina. Signs of an allergic reaction may include intensified redness, swelling, itching, or hives that extend beyond the application site. If you suspect an allergic reaction, discontinue use immediately and contact your healthcare provider.

Applying capsaicin to broken or inflamed skin can cause excessive absorption and severe irritation. The skin barrier function must be intact for safe topical application. If you have recently had shingles, wait until the rash has completely healed and all blisters have crusted over and resolved before applying Capsina. Areas of active dermatitis, eczema, psoriasis, or other skin conditions should also be avoided.

Warnings and Precautions

The most important precaution when using Capsina is proper hand hygiene after application. Capsaicin is an extremely potent irritant, and even trace amounts transferred from the hands to the eyes, nose, mouth, or other sensitive areas can cause intense burning pain. It is recommended to wash hands with soap and water at least three times after application to remove residual capsaicin. Some patients find it helpful to use disposable gloves or finger cots when applying the cream, although this is not required.

Airborne capsaicin can also be an issue. When the cream dries on the skin surface, small particles of capsaicin may become airborne and irritate the respiratory tract, leading to coughing, sneezing, or difficulty breathing. This risk is generally higher in enclosed, poorly ventilated spaces. Ensure adequate ventilation after applying the cream, and avoid touching or rubbing the treated area once the cream has dried.

If you are using other topical medications on the same area, discuss this with your healthcare provider. While no formal interaction studies have been conducted with Capsina in combination with other topical preparations, applying multiple products to the same skin area may alter absorption or increase the risk of irritation.

Use in Children

Capsina should not be used in children. There is no clinical experience with the use of capsaicin cream in pediatric patients, and safety and efficacy have not been established in this age group. Post-herpetic neuralgia is overwhelmingly a condition of older adults, and the TRPV1 receptor system in children may respond differently to capsaicin exposure. If a child accidentally ingests or applies Capsina, seek medical advice immediately.

Pregnancy and Breastfeeding

The safety of Capsina during pregnancy has not been established. There is insufficient data to determine whether capsaicin can affect fetal development when applied topically. It is also unknown whether capsaicin passes into breast milk. Although systemic absorption from topical application is minimal, the theoretical risk cannot be entirely excluded.

If you are pregnant, breastfeeding, suspect you may be pregnant, or are planning to become pregnant, you should consult your doctor or pharmacist before using Capsina. Your healthcare provider will assess whether the potential benefits of treatment outweigh any theoretical risks. Alternative pain management strategies may be considered during pregnancy and lactation.

Driving and Operating Machinery

Capsina is not known to affect the ability to drive or operate machinery. The medication acts locally on the skin and has negligible systemic absorption, so it does not cause drowsiness, dizziness, or any other central nervous system effects that could impair these activities.

Important Information About Certain Ingredients

How Does Capsina Interact with Other Drugs?

Capsina acts locally on the skin and is absorbed systemically in only very small amounts. Because of this limited systemic bioavailability, clinically significant pharmacokinetic interactions with other medications are not expected. No formal studies have been conducted to evaluate the interaction of Capsina with other drugs, either topical or systemic.

However, as with any medication, it is important to tell your doctor or pharmacist about all medicines you are currently using, have recently used, or might use. This includes prescription medications, over-the-counter drugs, herbal preparations, and dietary supplements. The following general considerations apply:

Topical Drug Interactions

Although no specific topical interactions have been documented, caution is advised when applying other topical products to the same skin area being treated with Capsina. Products that compromise the skin barrier, such as topical retinoids, alpha-hydroxy acids, or other exfoliating agents, could theoretically increase the absorption and irritation potential of capsaicin. Similarly, concurrent use of other topical analgesics (such as menthol-based or salicylate-based creams) on the same area is not recommended, as the combined irritant effects could be additive.

Systemic Drug Interactions

Due to the negligible systemic absorption of capsaicin from topical application, interactions with oral or injectable medications are not expected. Capsaicin does not undergo hepatic metabolism via cytochrome P450 enzymes to any clinically relevant degree when applied topically, so it is unlikely to affect the metabolism of co-administered systemic drugs.

Patients taking ACE inhibitors should be aware that capsaicin may, in theory, enhance the cough reflex associated with these medications if airborne capsaicin particles are inhaled. This interaction is pharmacodynamic rather than pharmacokinetic and is related to the irritant properties of capsaicin on airway sensory nerves rather than any drug-drug interaction per se. Patients using ACE inhibitors who develop a persistent cough while using Capsina should discuss this with their physician.

There is some theoretical evidence from in vitro studies that capsaicin may influence platelet aggregation at very high systemic concentrations. However, the extremely low systemic levels achieved with topical application of Capsina 0.075% make this clinically irrelevant, and no dose adjustments of anticoagulant or antiplatelet medications are necessary.

What Is the Correct Dosage of Capsina?

Always use Capsina exactly as your doctor has prescribed. If you are unsure, consult your doctor or pharmacist. The dosage recommendations below provide general guidance, but individual treatment plans may vary based on the severity of pain, the size of the affected area, and individual patient response.

Adults

The amount of cream needed per application depends on the size of the affected area. A pea-sized amount (approximately 0.5 cm ribbon of cream) is typically sufficient for an area roughly the size of the palm of the hand. The cream should be applied in a thin, even layer and gently massaged into the skin.

It is crucial to maintain a regular application schedule without interruption. The therapeutic effect of capsaicin depends on sustained desensitization of nerve fibers, which requires consistent exposure. Skipping applications or applying the cream irregularly can delay the onset of pain relief or reduce its effectiveness. Most patients begin to notice improvement after 1–2 weeks of regular use, although some individuals may require up to 4 weeks for the full analgesic effect to develop.

If, after an adequate trial period (typically 6–8 weeks of regular use), there is no significant improvement in pain, consult your doctor to reassess the treatment strategy. There is limited evidence to support continued use beyond 8 weeks without clinical benefit.

Children

Capsina should not be used in children or adolescents under 18 years of age. There is no clinical experience with capsaicin cream in the pediatric population, and the safety and efficacy of this product have not been established in this age group. The developing nervous system of children may respond differently to capsaicin-induced TRPV1 desensitization, and the potential for adverse effects has not been adequately studied.

Elderly Patients

No dosage adjustment is required for elderly patients. Post-herpetic neuralgia is most common in older adults, and capsaicin cream has been widely studied and used in this population. Elderly patients should follow the same application instructions as other adults. However, it is worth noting that older adults may have thinner, more fragile skin, which could theoretically increase sensitivity to the initial burning sensation. Starting with less frequent application (twice daily) and gradually increasing to the recommended 3–4 times daily may be a practical approach for patients who find the initial burning sensation particularly bothersome.

Missed Dose

If you forget to apply Capsina at the scheduled time, apply it as soon as you remember, and then continue with your regular application schedule. Do not apply a double amount to compensate for a missed application. Keep in mind that irregular use may delay or reduce the therapeutic effect, as the pain-relieving mechanism depends on continuous desensitization of nerve fibers.

Overdose

Topical overdose (applying too much cream) will primarily cause an intensification of the local burning and warming sensations. The affected area can be washed with soap and water to remove excess cream. Cool compresses may help relieve discomfort. Applying vegetable oil or a lipid-based cream to the area can also help, as capsaicin is lipophilic and dissolves more readily in oils than in water.

What Are the Side Effects of Capsina?

Like all medicines, Capsina can cause side effects, although not everyone experiences them. The most characteristic side effect is a transient sensation of warmth, burning, or stinging at the site of application. This is a pharmacological effect of capsaicin and is directly related to its mechanism of action: the activation of TRPV1 receptors on sensory nerve fibers before desensitization occurs.

The initial burning sensation is most intense during the first few days of treatment and typically diminishes progressively over the first 1–2 weeks as the nerve endings become desensitized. Approximately 40–60% of patients experience some degree of application-site burning, with most describing it as mild to moderate. The sensation usually begins within minutes of application and can last from 30 minutes to 2 hours. It is important not to discontinue treatment because of this expected effect, as it generally improves with continued regular use.

The respiratory effects (coughing, sneezing, breathing difficulties) can occur when capsaicin particles from the dried cream become airborne and are inhaled. This is more likely to happen if the treated area is rubbed or if clothing is removed near the face after contact with the treated area. Patients with asthma or chronic obstructive pulmonary disease (COPD) should be particularly cautious, as capsaicin can trigger bronchospasm in susceptible individuals.

If you experience any side effects that are severe, persistent, or concerning, or if you notice effects not listed here, please report them to your healthcare provider. Reporting suspected adverse reactions after a medicine has been authorized is important, as it allows ongoing monitoring of the medicine’s benefit-risk profile. Healthcare professionals and patients are encouraged to report adverse reactions to their national pharmacovigilance authority.

Managing Application-Site Burning

Several strategies can help manage the initial burning sensation associated with Capsina use:

• Apply consistently: The burning diminishes faster with regular, uninterrupted use as nerve desensitization progresses.
• Cool compress: A cool (not cold) damp cloth applied over the treated area can help reduce the burning sensation.
• Avoid heat: Hot baths, showers, or heating pads applied to the treated area shortly before or after application can intensify the burning sensation.
• Thin layer: Use only a thin layer of cream. Excessive application does not improve efficacy but may increase burning.
• Gradual introduction: Some clinicians recommend starting with twice-daily application and gradually increasing to 3–4 times daily over the first week.

How Should You Store Capsina?

Proper storage of Capsina ensures that the medication remains safe and effective throughout its shelf life. The following storage guidelines should be observed:

• Keep out of the sight and reach of children. Capsaicin cream can cause significant discomfort if a child applies it to their skin or, more seriously, if ingested or rubbed into the eyes.
• No special storage conditions are required. Capsina can be stored at room temperature. Avoid exposing the tube to extreme heat or direct sunlight for prolonged periods.
• Check the expiry date. Do not use Capsina after the expiry date stated on the packaging. The expiry date refers to the last day of the stated month.
• Replace the cap securely after each use to prevent the cream from drying out and to minimize the risk of contamination.
• Do not dispose of medicines in wastewater or household waste. Return unused or expired medication to your pharmacist for proper disposal. This helps protect the environment.

Capsina is supplied in a 45-gram aluminum tube. Once opened, the cream should remain stable for the duration of its shelf life, provided the tube is properly sealed between uses. If the cream has changed in color, consistency, or odor, do not use it and consult your pharmacist about obtaining a replacement.

What Does Capsina Contain?

Active Ingredient

The active substance in Capsina is capsaicin. Each gram of cream contains 0.75 mg of capsaicin, corresponding to a concentration of 0.075%. Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a naturally occurring alkaloid found in the fruits of plants in the Capsicum family, including chili peppers. It is the compound responsible for the characteristic pungency and heat of chili peppers. For pharmaceutical use, capsaicin is typically produced through extraction from natural sources or by chemical synthesis to ensure consistent purity and concentration.

Inactive Ingredients (Excipients)

Appearance and Packaging

Capsina is a white, soft cream supplied in a 45-gram aluminum tube. The tube is sealed with a screw cap and packaged in a cardboard box along with the patient information leaflet. The cream should be uniform in texture and white to off-white in color. If the cream appears discolored, has separated, or has an unusual odor, do not use it and consult your pharmacist.